biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > I do find the "thumbs up" tallies funny

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 25, 2023 5:36pm

122 Views

Post# 35246484

RE:RE:I do find the "thumbs up" tallies funny

of course they can't. all you have to do is create an email address (very easy to do). you have many aliases here. we know it and you know it. don't act surprised.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?